Meta AnalysisID 4043

氯喹、羟氯喹及奎宁在临床和体内研究中对病毒感染的作用:系统评价与Meta分析

CRD42020183429

Have chloroquine, hydroxychloroquine or quinine shown consistent beneficial effects on survival, organ injury, viral clearance or other biologic markers during viral infection in published clinical and in vivo animal stu

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
4043
Evidence Id
12601
Core Evidence Id
12601
Source Meta Analysis Id
4003
Herb2 Meta Analysis Id
HBMA004003
Crd Id
CRD42020183429
Title
Effects of chloroquine, hydroxychloroquine and quinine in viral infection in clinical and in vivo studies: a systematic review and meta-analysis
Review Question
Have chloroquine, hydroxychloroquine or quinine shown consistent beneficial effects on survival, organ injury, viral clearance or other biologic markers during viral infection in published clinical and in vivo animal studies?
Study Type Included
Published clinical and in vivo animal studies that compared the effects of chloroquine, hydroxychloroquine or quinine to a control group on survival, organ injury, viral clearance or other biologic markers during viral infection.
Condition Being Studied
Chloroquine, hydroxychloroquine and quinine have been used as anti-infective therapies for malaria and as anti-inflammatory therapies for rheumatoid arthritis and several other connective tissue diseases. These agents have been strongly recommended for use in patients during the COVID-19 outbreak but reports are beginning to emerge regarding their adverse and harmful effects. The goal of the present systematic review and analysis is to determine how strong prior published evidence was in patients and in in vivo animal models suggesting that these agents would have beneficial anti-viral effects during COVID-19 infection.
Participant
Patients or animals with natural viral infection or receiving a viral challenge of any type treated with chloroquine, hydroxychloroquine or quinine or control and in which the effects of these treatments on survival, organ injury, viral clearance or other biologic markers were assessed.
Animal
Human Disease Modelled
Intervention
Reports will be retrieved and examined that compared intervention with chloroquine, hydroxychloroquine or quinine versus a control material during viral infection in patients or animals.
Comparator Control
Placebo or diluent/carrier for the animal studies
Main Outcome
Survival with natural viral infection or following a viral challenge as defined in each retrieved report. If multiple survival outcomes are provided, the one of longest duration will be included in analysis. Measures of effect Relative Risk
Outcome Measure
Additional Outcome
1. Organ injury 2. Viral clearance 3. Other biologic markers Measures of effect Relative Risk
Study Method
Meta-analysis, Systematic review
Keyword
Chloroquine; COVID-19; Humans; Hydroxychloroquine; Quinine; Virus Diseases
Contact
Parizad Torabi-Parizi [email protected]
Organisational Affiliation
National Institutes of Health
Funding Source
Intramural research funding from the Clinical Center, National Institutes of Health Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span>
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
United States of America
Review Stage
Review Ongoing
First Submission Date
2020-04-30
Registration Date
2020-05-01
Anticipated Start Date
2020-04-24
Anticipated Completion Date
2020-07-01
Title Cn
氯喹、羟氯喹及奎宁在临床和体内研究中对病毒感染的作用:系统评价与Meta分析
Title En
Effects of chloroquine, hydroxychloroquine and quinine in viral infection in clinical and in vivo studies: a systematic review and meta-analysis
Bilingual Status
complete